Drugs / Meningococcal A+C vaccine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01187433 Comparator | Aug 2010 → Oct 2012 | Dengue hemorrhagic fever | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Meningococcal A+C vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01187433 ↗ |
| Modality | Vaccine | “Meningococcal A+C vaccine” NCT01187433 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular” NCT01187433 ↗ |